Aspirin inhibits LPS-induced macrophage activation via the NF-κB pathway

Area of Science:

• Immunology
• Regenerative Medicine
• Pharmacology

Background:

• Aspirin (acetylsalicylic acid) promotes bone regeneration by affecting mesenchymal stem cells.
• The impact of aspirin on immune cells during bone formation is not well understood.

Purpose of the Study:

• To investigate aspirin's effect on macrophage activation during inflammation.
• To explore aspirin's role in modulating immune responses relevant to bone regeneration.

Main Methods:

• Assessed macrophage activation markers (iNOS, TNF-α, FIZZ/YM-1/ARG1) in vitro using LPS and IL-4 stimulation.
• Utilized mouse peritoneal macrophages and RAW264.7 cell lines.
• Created a rat mandibular bone defect model to evaluate aspirin's in vivo efficacy.

Main Results:

• Aspirin downregulated iNOS and TNF-α expression in LPS-induced macrophages via NF-κB and COX2/PGE2 pathways.
• Aspirin did not affect IL-4-induced alternative macrophage activation markers.
• In vivo, aspirin improved bone regeneration by inhibiting early-stage inflammation-induced macrophage activation.

Conclusions:

• Aspirin modulates macrophage activation pathways, reducing pro-inflammatory responses.
• Aspirin enhances bone regeneration, particularly in inflammatory contexts.
• Aspirin represents a potential therapeutic strategy for improving bone healing during inflammation.